ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q4Scopus Q3SCImago #13,657Top JournalReview JournalHybrid

Clinical Neuropharmacology

Acronym:cnp
•
Abbreviation (ISO):CLIN. NEUROPHARMACOL
•
Identifier (ISSN):0362-5664(Print)/1537-162X(Online)
•
Publisher:Lippincott Williams and Wilkins Ltd.
Clarivate IF (2026)
1.2↓ -0.3
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Clinical Neuropharmacology

WoS Q4
01231.3720181.2720191.2920201.5920211.382022120230.820241.520251.22026
Annual Impact Factor Metric
Current (2026):1.2
Scopus SJR & RankScopus Q3
0.422
#13,657

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
90

90 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
62articles/year
6.78% Gold OA•2.44% Original Research

Aims & Scope

Clinical Neuropharmacology is a peer-reviewed journal devoted to the pharmacology of the nervous system in its broadest sense. Coverage ranges from such basic aspects as mechanisms of action, structure-activity relationships, and drug metabolism and pharmacokinetics, to practical clinical problems such as drug interactions, drug toxicity, and therapy for specific syndromes and symptoms. The journal publishes original articles and brief reports, invited and submitted reviews, and letters to the editor. A regular feature is the Patient Management Series: in-depth case presentations with clinical questions and answers.

Topics Covered (Recognized by AI)
MedicineBiologyPsychologyInternal MedicinePsychiatryNeuroscienceChemistryEndocrinologyPharmacologyBiochemistryGeneticsPathologyAnesthesiologyReceptors & PharmacologyPathology & DiseasesComputer Science
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CLINICAL NEUROLOGY

Q4
Rank250/296
IndexSCIE
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q4
Rank307/356
IndexSCIE
JCISCIE2026

CLINICAL NEUROLOGY

Q4
Rank269/296
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q4
Rank316/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.2
Articles / Year26
Total Citations2
2025
IF1.5
Articles / Year46
Total Citations28
2024
IF0.8
Articles / Year40
Total Citations104
2023
IF1
Articles / Year41
Total Citations177
2022
IF1.379
Articles / Year50
Total Citations330

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #13,657Scopus Q3SCImago Profile
Scopus Coverage:1982-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q3
0.422

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
1.35

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,717 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations217
3-Year Documents128
Citable Documents125

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Neurology (clinical)Q3
PharmacologyQ3
Pharmacology (medical)Q3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区CLINICAL NEUROLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Clinical Neuropharmacology (acronym: cnp, abbr: CLIN. NEUROPHARMACOL, ISSN: 0362-5664) is a peer-reviewed international scholarly journal in the field of Medicine, published by Lippincott Williams and Wilkins Ltd. in United States since 1976. The periodical holds a Journal Impact Factor (JIF) of 1.20, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.422 (Q3), an H-index of 90.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 62 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,717 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Lippincott Williams and Wilkins Ltd.
Publication Language
English
Frequency
Bimonthly
Founding Year
1976
Indexing & Databases
SCIEScopusPubMed
Editorial Address
LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 55cd3722-f34a-4213-9fb5-87bedce7b6de
Database Updated: 2026-09-28